Senores Pharmaceuticals Limited has informed the Exchange about Intimation under regulation 30 of Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals Limited has submitted a disclosure to NSE under SEBI's Listing Regulations (Regulation 30), which covers material events that listed companies must report. The filing headline does not specify what the actual announcement is about — no event details, numbers, or context are included in the text provided. Without the underlying content, it is not possible to determine whether this relates to a business update, board decision, financial result, or other corporate action.
Impact on shareholders or stock price cannot be assessed from the information given, as the filing lacks substantive details about the event being disclosed.